Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of SGN-CD47M in Patients With Advanced Solid Tumors

NCT03957096 is registered in ClinicalTrials.gov with Seagen Inc. as lead sponsor.

NCT NCT03957096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03957096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of SGN-CD47M in Patients With Advanced Solid Tumors
Lead sponsor
Seagen Inc.
Phase
Phase 1
Overall status
Terminated
Start date
July 17, 2019
Completion date
September 14, 2020
Enrollment
16 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, colorectal cancer, exocrine pancreatic carcinoma, gastric carcinoma, head and neck squamous cell carcinoma, melanoma, non-small cell lung carcinoma, ovarian carcinoma, soft tissue sarcoma